Alternatives to SexyMD

The widest menu on our roster — injections, sublingual lozenges, daily drops, four brand-name pens and the approved oral GLP-1 — with three compounding pharmacies named, a flat price at any dose, and cancellation terms among the most restrictive we have read.

• $70/mo cheaper than SexyMD
• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject

Now confirmed to publish real GLP-1 prices — compounded semaglutide from $199, tirzepatide from $349, plus brand options — right on its products page, no consult required, contrary to what an earlier check found.

• $70/mo cheaper than SexyMD
• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject

RxSpan MD is a genuinely well-disclosed service wrapped in marketing that undercuts it. The disclosure: four compounding pharmacies named with phone numbers, two lead physicians named with NPI numbers that verify as active MDs, flat pricing posted before any intake, both compounded and real FDA-approved brand GLP-1s on one platform, and oral capsules for anyone who won't inject. Compounded semaglutide is $249 a month and tirzepatide $329, with brand Zepbound at $1,069, Ozempic at $1,299 and Wegovy at $1,349. The marketing is the problem. Its testimonials still name a different company — one patient describes what she 'expected from CareGLP' — and the doctors quoted in them are not the clinicians the same page names as its medical team. The homepage is built around a board-certified plastic surgeon who founded the practice but is licensed in California only and isn't the prescriber. Its compounded prices also sit above the roster median, and the oral capsules cost the same or more than the injections.

• $20/mo cheaper than SexyMD
• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject

Injection or sublingual, both molecules — but we list it only with full disclosure: a 2025 FDA warning letter and a BBB complaint pattern around surprise 3-month charges make cancellation the real risk here.

• $20/mo cheaper than SexyMD
• has an oral option if you would rather not inject
• scores 70/100 against SexyMD's 32

One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.

• $20/mo cheaper than SexyMD
• scores 81/100 against SexyMD's 32

A clean, all-50-states compounded option with named pharmacies, no membership and the consult included — reasonable and transparent on price, though it's a newer platform with thin public detail beyond the $199 headline.

• $70/mo cheaper than SexyMD
• has an oral option if you would rather not inject
• scores 78/100 against SexyMD's 32

⛔ FDA warning letter #728279 (June 2026), which names tryeden.com. The most oversight-forward compounded program here — visible clinician involvement and lab framing — at $196/mo semaglutide or $296/mo tirzepatide, flat and nationwide.

• $73/mo cheaper than SexyMD
• scores 89/100 against SexyMD's 32

The most complete set of routes on this roster — a real branded lane through insurance or LillyDirect, a compounded lane that charges the same for tirzepatide as for semaglutide, and a non-GLP-1 generics lane — undercut by a three-day refund window and a complaint pattern that sits squarely on billing.

• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject
• scores 74/100 against SexyMD's 32

Both molecules have confirmed, tiered pricing, which appears only inside the signup flow — the public site carries no price at all — with a real gotcha: the 3-month plan costs more per month than month-to-month.

• $70/mo cheaper than SexyMD
• offers FDA-approved brand pens, not just compounded
• scores 71/100 against SexyMD's 32